Metabotissugenic citrate biomaterials orchestrate bone regeneration via citrate-mediated signaling pathways
Science Advances · 2025
DOI: 10.1126/sciadv.ady2862 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Hui Xu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, The Pennsylvania State University, University Park, PA 16802, USA. Hauptthemen laut MEDLINE: Bone Regeneration, Biocompatible Materials, Signal Transduction, Citric Acid. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NINDS NIH HHS.
Abstract (Originalsprache)
Bone regeneration requires coordinated anabolic and catabolic signaling, yet the interplay between mammalian target of rapamycin complex 1 (mTORC1) and adenosine monophosphate–activated protein kinase (AMPK) pathways remains unclear. This study reveals that citrate, glutamine, and magnesium synergistically activate both pathways via calcium/calmodulin-dependent protein kinase kinase 2 (CaMKK2)– and protein kinase B (Akt)–dependent signaling, bypassing the traditional adenosine monophosphate (AMP)/adenosine triphosphate (ATP) sensing mechanism. This dual activation supports sustained energy metabolism during osteogenesis and challenges the canonical antagonism between mTORC1 and AMPK. We developed CitraBoneQMg, a citrate-based biomaterial incorporating these components via one-pot synthesis. CitraBoneQMg provides sustained release, photoluminescent and photoacoustic imaging capabilities, and tunable mechanical properties. In vitro, it promotes osteogenesis by enhancing alkaline phosphatase (ALP) activity, osteogenic gene expression, and calcium deposition. In vivo, it accelerates bone regeneration in a rat calvarial defect model while promoting anti-inflammatory and neuroregenerative responses. We define this integrated effect as “metabotissugenesis,” offering a metabolically optimized approach to orthopedic biomaterial design.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, The Pennsylvania State University, University Park, PA 16802, USA.
- Department of Traumatic Surgery, Center for Orthopaedic Surgery, The Third Affiliated Hospital of Southern Medical University, Guangzhou, Guangdong, PR China.
- Department of Materials Science and Engineering, Westlake University, Hangzhou, Zhejiang 310030, PR China.
- Department of Neurosurgery, Dell Medical School, University of Texas at Austin, Austin, TX 78712, USA.
- Department of Orthopedics and Rehabilitation College of Medicine, The Pennsylvania State University, Hershey, PA 17033, USA.
- Research Center for Industries of the Future, Westlake University, Hangzhou, Zhejiang 310030, PR China.
ORCID-Profile: Hui Xu, Xinyu Tan, Hao Zhang, Sri-Rajasekhar Kothapalli, April D Armstrong, Su Yan, Jian Yang
Förderung
- NHLBI NIH HHS
- NINDS NIH HHS
Zitieren
APA
Xu, H., Tan, X., Gerhard, E., Zhang, H., Ray, R., Wang, Y., Kothapalli, S. R., Rizk, E. B., Armstrong, A. D., Yan, S., & Yang, J. (2025). Metabotissugenic citrate biomaterials orchestrate bone regeneration via citrate-mediated signaling pathways. Science Advances. https://doi.org/10.1126/sciadv.ady2862
Vancouver
Xu H, Tan X, Gerhard E, Zhang H, Ray R, Wang Y, et al. Metabotissugenic citrate biomaterials orchestrate bone regeneration via citrate-mediated signaling pathways. Science Advances. 2025. doi:10.1126/sciadv.ady2862
BibTeX
@article{Xu2025,
author = {Xu, Hui and Tan, Xinyu and Gerhard, Ethan and Zhang, Hao and Ray, Rohitraj and Wang, Yuqi and Kothapalli, Sri-Rajasekhar and Rizk, Elias B and Armstrong, April D and Yan, Su and Yang, Jian},
title = {Metabotissugenic citrate biomaterials orchestrate bone regeneration via citrate-mediated signaling pathways},
journal = {Science Advances},
year = {2025},
doi = {10.1126/sciadv.ady2862}
}
EUVIMED